Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Procedure
  • Participants: 20
  • Start Date: December 1, 2021
Evaluation of Cryo-Immune Stimulation in Mesothelioma
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug, Device
  • Participants: 20
  • Start Date: September 2021
Intrapleural Photodynamic Therapy by Video-Assisted Thoracoscopy Followed by Anti-PD-1 NIVOLUMAB in Patients With Malignant Pleural Mesothelioma - a Pilot Study
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 156
  • Start Date: August 27, 2021
An Open-label, Multi-center, Phase I Study of Oral IAG933 in Adult Patients With Advanced Mesothelioma and Other Solid Tumors
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Procedure
  • Participants: 20
  • Start Date: July 1, 2021
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 10
  • Start Date: June 2021
Pilot and Feasibility Study of Intravenous Magnesium in Patients Receiving Hyperthermic Intraoperative Chemotherapy With Cisplatin (HIOCC)
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Genetic
  • Participants: 30
  • Start Date: June 2021
Molecular, Pathologic Intra Tumoral Heterogeneity in Malignant Pleural Mesothelioma
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1
  • Intervention Type: Biological, Drug
  • Participants: 20
  • Start Date: May 5, 2021
Phase I Study of Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 141
  • Start Date: April 12, 2021
Efficacy of Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors Defined by a Single and Pre-specified Cutoff
Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other, Diagnostic Test, Drug
  • Participants: 100000
  • Start Date: April 5, 2021
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 56
  • Start Date: April 2021
Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma
Showing 1-12 of 148